:

QUANTHEALTH RAISES $45M IN SERIES B FUNDING

AI DESK1 MIN READ
MON, AUG 10, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Tel Aviv-based QuantHealth, an AI clinical trial simulation software provider, secured $45M in Series B funding led by Qumra Capital. The round brings the company's total funding to approximately $70M.

QuantHealth develops artificial intelligence software designed to simulate clinical trials, helping pharmaceutical companies optimize trial design and predict outcomes before launching expensive real-world studies. The Series B funding validates growing demand for AI-driven solutions in drug development. Clinical trial simulation technology can reduce development timelines and costs by identifying optimal trial parameters early in the process. Qumra Capital's leadership of the round signals confidence in QuantHealth's market position within the biotech AI sector. The company joins a growing wave of Israeli startups leveraging AI for healthcare applications. With $70M in total funding, QuantHealth is positioned to expand its platform capabilities and increase its presence in markets beyond Israel, where pharmaceutical companies face mounting pressure to accelerate drug development cycles while managing costs.

■ SOURCES

Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

The AI-focused hedge fund Situational Awareness has invested $400 million in chip startup Source Foundry, signaling continued confidence in semiconductor plays despite recent headwinds.

8H AGOIndustry Desk

Munich-based spatial data platform NavVis secured $85 million in Series D funding led by The Jordan Company. The round supports the company's mission to digitize physical spaces for enterprises.

22H AGOAI Desk

Defense tech company Hadrian secured $1.37 billion in Series D funding at an $8 billion valuation. The capital will fund expansion of its manufacturing facilities and Opus software platform.

AUG 8AI Desk

Singapore-based AI infrastructure startup Acrab raised $130 million in Series B funding, surpassing $480 million in total capital raised. The round was backed by existing investors including Vertex Ventures.

AUG 7AI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.